GSK announces positive interim results from registrational phase II AZUR-1 trial of Jemperli in dMMR/MSI-H locally advanced rectal cancer: London, UK Tuesday, July 14, 2026, 12:00 ...

July 13 (Reuters) - GSK said on Monday its cancer drug Jemperli met the primary goal of a mid-stage trial, with a clinically ...

In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...

At MSK, close to half of the surgeries just for colorectal cancer are done robotically, Dr. Garcia-Aguilar says. A leader in ...

Vienna, Austria – Rectal cancer is a type of bowel cancer that develops in the last several centimetres of the large intestine, just before the anus. It’s one of the most common cancers in Europe, ...

Stage 3 colorectal cancer patients with MRD benefit from Celebrex addition to chemotherapy, showing a 40% risk reduction in death for Signatera-positive patients. Celebrex improved disease-free and ...

Rectal cancer is a type of bowel cancer that develops in the last several centimeters of the large intestine, just before the anus. It’s one of the most common cancers in Europe, with over 125,000 ...

A short course of immunotherapy given before surgery eliminated detectable colon cancer in a majority of patients whose ...

Patients who have undergone surgery for colorectal cancer experience fewer serious complications and fewer readmissions when an AI tool supports treatment decisions, according to new research. The ...